AANS and CNS Release Position Statement on Hydrocodone Prescribing
Last week, the AANS and CNS issued a position statement on Hydrocodone Prescribing Policy, which was developed by the AANS/CNS Section on Pain to address action taken earlier this year by the FDA’s Drug Safety and Risk Management Advisory Committee imposing significantly stricter prescribing rules on drugs containing hydrocodone…